PASSION FOR IDEAS

CeQur

CeQur is a medical technology company, which has developed an insulin infuser for the care of type 2 Diabetes mellitus patients.

The CeQur device is a small discreet and wearable insulin patch infuser. It will be one of the smallest and easiest continuous delivery options as it will administer the basal and bolus rates of insulin over three days. The CeQur insulin infuser includes a disposable insulin reservoir that is connected to a reusable electronic messenger. The device easily attaches to the patient's abdominal area with a safe and secure adhesive backing. The product will go into clinical trial in 2010 in Europe. It will compete with delivery pens and syringes on the market, but with the proposed benefit of avoiding daily self-injections, which should increase patients’ compliance and clinical outcome.


Recent News

January 5, 2010
CeQur SA Completes Series A Investment with 10 Million Dollar Raise in December 2009

 
October 7, 2009
CeQur SA Appoints Eric Milledge Chairman of the Board of Directors

 


Company Info
 
Country: Switzerland
Industry:    LS
Sector: medical technology
Status: Unrealized
Vehicle: Endeavour II LP


Key persons
 Eric Milledge, Chairman; James Peterson, CEO


Company website
 www.cequrcorp.com


Endeavour Vision Team
 
Damien Tappy
Daniel Bertholet
partner of the European Tech Tour "The Endeavour Vision team have been much more supportive and additive than others I have worked with the past. When our company was spun-off from Danfoss incubator, they gave us a great amount of support in the administrative load of a start-up, and worked hard to learn the details of the market and opportunity. Consequently, they have supported our company tremendously over the years, from day-to-day operations to strategic direction."
James Peterson, CEO and Chairman, CeQur SA